See more : Gamida Cell Ltd. (GMDA) Income Statement Analysis – Financial Results
Complete financial analysis of Amplitude Healthcare Acquisition Corporation (AMHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Amplitude Healthcare Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- NervGen Pharma Corp. (NGENF) Income Statement Analysis – Financial Results
- Peak Resources LP (PRB) Income Statement Analysis – Financial Results
- Satellos Bioscience Inc. (MSCL.TO) Income Statement Analysis – Financial Results
- Captiva Verde Wellness Corp. (PWR.CN) Income Statement Analysis – Financial Results
- Quantum Graphite Limited (QGL.AX) Income Statement Analysis – Financial Results
Amplitude Healthcare Acquisition Corporation (AMHC)
About Amplitude Healthcare Acquisition Corporation
Amplitude Healthcare Acquisition Corporation does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare related industries. The company was founded in 2019 and is based in New York, New York.
| Metric | 2020 |
|---|---|
| Revenue | 0.00 |
| Cost of Revenue | 0.00 |
| Gross Profit | 0.00 |
| Gross Profit Ratio | 0.00% |
| Research & Development | 0.00 |
| General & Administrative | 935.40K |
| Selling & Marketing | 0.00 |
| SG&A | 935.40K |
| Other Expenses | 0.00 |
| Operating Expenses | 935.40K |
| Cost & Expenses | 935.40K |
| Interest Income | 383.15K |
| Interest Expense | 0.00 |
| Depreciation & Amortization | 383.15K |
| EBITDA | -552.25K |
| EBITDA Ratio | 0.00% |
| Operating Income | -935.40K |
| Operating Income Ratio | 0.00% |
| Total Other Income/Expenses | 383.15K |
| Income Before Tax | -552.25K |
| Income Before Tax Ratio | 0.00% |
| Income Tax Expense | 38.45K |
| Net Income | -590.70K |
| Net Income Ratio | 0.00% |
| EPS | -0.05 |
| EPS Diluted | -0.05 |
| Weighted Avg Shares Out | 12.50M |
| Weighted Avg Shares Out (Dil) | 12.50M |
Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy
AMHC Stock: Why It Substantially Increased Today
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Amplitude Healthcare Acquisition Corp. - AMHC
'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines
Source: https://incomestatements.info
Category: Stock Reports